[Limited operation for stage I lung cancer: a retrospective study].
Although lobectomy is standard therapy for Stage I non-small cell lung cancer, it often cannot be performed in poor-risk patients. In this report, we describe the results of a retrospective study to assess the usefulness of limited operation for stage I lung cancer. Over a 21-year period, 1,286 lung cancers were resected at our center. Among the 497 patients with stage I lung cancer, 36 sublobar resections were performed. There was only one surgery-related death, and the 5-year survival rate was 46% for all patients. At 5 years, survival was 69.2% for patients with squamous cell carcinoma and 33.7% for patients with adenocarcinoma. Survival rates were higher in patients who underwent mediastinoscopy than those who did not, and depended on histological findings and accurate pathological staging.
Katakura
H
H
Respiratory Disease Center, Kyoto Katsura Hospital, Japan.
Yamashita
N
N
Iwakiri
S
S
Ozaki
Y
Y
Nagai
S
S
Okazaki
T
T
Hanawa
T
T
Yasuda
Y
Y
Misaki
K
K
Hatakenaka
R
R
Matsubara
Y
Y
Funatsu
T
T
Ikeda
S
S
D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery; D000368:Aged; D000369:Aged, 80 and over; D018288:Carcinoma, Small Cell / Q000401:mortality / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000601:surgery; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011013:Pneumonectomy / Q000379:methods*; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate